Dr. Chu is a Clinician Scientist at the Cross Cancer Institute. He completed his medical degree, residency, and Medical Oncology Fellowship at the University of Alberta. His clinical focus includes lymphoma, myeloma, and central nervous system malignancies. Academically, his research focuses on basic and translational cancer research with an emphasis on immune therapy. Dr. Chu also serves as principal investigator and sub-principal investigator on multiple phase I, II, and III clinical trials.